Gainers
- Kodiak Sciences Inc. KOD shares climbed 108.3% to $61.67 after the company reported the sale of future royalties on KSI-301 for $225 million to Baker Bros. Advisors.
- ASLAN Pharmaceuticals Limited ASLN shares jumped 69.4% to $6.47 after the company reported positive data from its proof-of-concept study of ASLAN004.
- Onconova Therapeutics, Inc. ONTX shares rose 31.4% to $0.2471.
- NF Energy Saving Corporation BIMI shares gained 27.4% to $3.35 after the company announced it would acquire Chongqing Guanzan Technology for RMB 100 million.
- Oramed Pharmaceuticals Inc. ORMP rose 21.1% to $5.34 after climbing 17.91% on Friday.
- Aquestive Therapeutics, Inc. AQST climbed 20.5% to $9.39. Aquestive Therapeutics submitted New Drug Application to the FDA for Libervant.
- PDS Biotechnology Corporation PDSB gained 20.1% to $2.81.
- Galmed Pharmaceuticals Ltd. GLMD rose 12.4% to $5.06.
- Akerna Corp. KERN shares rose 12.2% to $8.37.
- Evofem Biosciences Inc EVFM gained 11.9% to $6.83 after the company's phase 2b study of Amphora for the prevention of Chlamydia and Gonorrhea met its primary and secondary endpoints.
- Novavax, Inc. NVAX climbed 11.3% to $5.40.
- China Automotive Systems, Inc. CAAS shares gained 9.8% to $3.48.
- Brainsway Ltd. BWAY rose 9.3% to $10.24.
- Afya Limited AFYA shares surged 9% to $30.00.
- Ocugen Inc OCGN surged 8.7% to $0.4122 after a company director Junge Zhang bought 270,000 shares at an average price of $0.37 per share. When an insider buys shares, the market may perceive it as a sign of confidence in the company's outlook.
- Akari Therapeutics, Plc AKTX rose 8.5% to $2.2342. Akari Therapeutics announced pivotal Phase III trial design of nomacopan in pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA), following the FDA meeting.
- Puma Biotechnology, Inc. PBYI gained 7.8% to $10.23. Puma Biotechnology extended its commercialization agreement with Pierre Fabre for NERLYNX to the Middle East, South Africa, Sudan and Turkey.
- AK Steel Holding Corporation AKS rose 7.1% to $2.9550.
- Revance Therapeutics, Inc. RVNC gained 7% to $19.16. Goldman Sachs initiated coverage on Revance Therapeutics with a Buy rating and a $25 price target.
- Xenon Pharmaceuticals Inc XENE climbed 4.2% to $12.32 after the company received a $50 million upfront payment from Neurocrine Biosciences for the rights to its Xenon's XEN901.
Check out these big penny stock gainers and losers
Losers
- Aqua Metals Inc AQMS shares tumbled 48.9% to $0.69 after the company announced a significant fire in one of its plants.
- Roku, Inc. ROKU fell 16.5% to $133.77. Morgan Stanley downgraded Roku from Equal-Weight to Underweight and announced a $110 price target.
- Paringa Resources Limited PNRL shares tumbled 16.4% to $1.83 after dropping 57.9% on Friday.
- Cancer Genetics, Inc. CGIX fell 14.5% to $7.53 after climbing 58.2% on Friday.
- Just Energy Group Inc. JE dropped 14% to $2.3420 after the company announced it would suspend its dividend on its Series A preferred stock.
- Lexicon Pharmaceuticals, Inc. LXRX shares fell 13.6% to $3.0505 after the FDA reiterated its prior decision and denied Lexicon's appeal of the complete response letter for its Sotagliflozin.
- FinVolution Group FINV dropped 12.5% to $2.5650.
- Apache Corporation APA fell 11.7% to $19.67 after the company said it would need to continue drilling, deeper than expected, for its new well off of Suriname.
- Sequans Communications S.A. SQNS tumbled 11.4% to $2.7380.
- Eloxx Pharmaceuticals, Inc. ELOX dropped 11.2% to $4.6349.
- Harpoon Therapeutics, Inc. HARP shares dipped 11.2% to $16.61.
- ObsEva SA OBSV fell 10.8% to $4.06. H.C. Wainwright reiterated ObsEva with a Buy and lowered the price target from $44 to $36.
- Molecular Templates, Inc. MTEM dropped 10.7% to $11.63.
- Exicure, Inc. XCUR fell 10.4% to $3.03.
- Sundial Growers Inc. SNDL shares declined 9.9% to $2.18.
- Aurora Mobile Limited JG dropped 9.2% to $2.18.
- The Trade Desk, Inc. TTD fell 9.3% to $238.74. Shares of several technology and growth stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US stocks further fell on worse-than-expected manufacturing data.
- Diana Shipping Inc. DSX dipped 9.2% to $3.16 following downbeat Q3 earnings.
- MongoDB, Inc. MDB declined 9.1% to $135.16.
- Alteryx, Inc. AYX dipped 8.7% to $103.71.
- Smartsheet Inc. SMAR dropped 8.4% to $43.46.
- Can-Fite BioPharma Ltd. CANF fell 7.6% to $3.2696 after rising 39.69% on Friday.
- Teladoc Health, Inc. TDOC fell 7% to $77.91. SunTrust Robinson Humphrey downgraded Teladoc Health from Buy to Hold and announced a $80 price target.
- Ideanomics Inc IDEX fell 4.4% to $0.8707 after the company announced a deal with the Providence of Inner Mongolia to provide electric vehicles and a metals trading platform.
AKTXAkari Therapeutics PLC
$1.049.47%
APAAPA Corp
$21.871.25%
AQMSAqua Metals Inc
$1.90-3.55%
AQSTAquestive Therapeutics Inc
$3.56-0.84%
BIMIBIMI Holdings Inc
$0.00110-47.6%
BWAYBrainsWay Ltd
$9.524.04%
CAASChina Automotive Systems Inc
$3.94-0.50%
CANFCan Fite Biofarma Ltd
$1.43-2.05%
DSXDiana Shipping Inc
$1.88-1.57%
ELOXEloxx Pharmaceuticals Inc
$0.000001-%
EVFMEvofem Biosciences Inc
$0.012231.2%
GLMDGalmed Pharmaceuticals Ltd
$3.308.91%
IDEXIdeanomics Inc COM NEW
$0.0800-90.9%
JGAurora Mobile Ltd
$5.91-4.06%
KODKodiak Sciences Inc
$9.998.05%
LXRXLexicon Pharmaceuticals Inc
$0.7600-8.10%
MDBMongoDB Inc
$242.80-0.05%
MTEMMolecular Templates Inc
$0.1113-20.5%
NVAXNovavax Inc
$8.50-1.62%
OCGNOcugen Inc
$0.7319-1.11%
ORMPOramed Pharmaceuticals Inc
$2.38-%
PBYIPuma Biotechnology Inc
$3.1010.3%
PDSBPDS Biotechnology Corp
$1.680.60%
ROKURoku Inc
$79.100.38%
RVNCRevance Therapeutics Inc
$3.06-0.33%
SMARSmartsheet Inc
$56.320.63%
SNDLSNDL Inc
$1.82-1.62%
SQNSSequans Communications SA
$3.103.33%
TDOCTeladoc Health Inc
$9.160.44%
TTDThe Trade Desk Inc
$123.951.87%
XCURExicure Inc
$17.04-12.8%
XENEXenon Pharmaceuticals Inc
$40.004.88%
FINVFinVolution Group
$6.971.46%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in